Skip to main content

Branded

  • FDA approves Intarosa for post-menopausal pain during sex
    SILVER SPRING, Md. — The Food and Drug Administration on Thursday announced its approval of Quebec-based EndoCeutics’s Intarosa, a treatment for postmenopausal women experiencing pain during sex, a condition known as dyspareunia and a symptom of vulvar and vaginal atrophy. The condition is the result of a decline in estrogen levels that occurs during menopause. 
     

  • Gilead names Meyers EVP worldwide commercial operations
    FOSTER CITY, Calif. — Gilead Sciences on Thursday announced the promotion of James Meyers to the position of EVP worldwide commercial operations. In the new position, Meyers, who has been with Gilead since 1996, will be responsible for all North American, European and Japanese business operations and will become an officer of the company and a member of its senior leadership team. 
     

  • Shire launches Cuvitru
    LEXINGTON, Mass. — Shire on Wednesday announced the launch of its Cuvitru (immune globulin subcutaneous (human) 20% solution). The drug, which was approved in September, is indicated to treat adult and pediatric patients aged two years and over with primary immunodeficiency — a group of more than 300 genetic disorders that prevent the immune system from functioning properly. 
     

  • Newly minted Veru Healthcare names VP marketing

    MIAMI - Veru Healthcare on Wednesday named Shiao Zhu VP marketing for Veru Healthcare, which manages both the pharmaceuticals and medical devices as well as the consumer health divisions of The Female Health Company.

  • Report: Trump’s hints at FDA reform could bode well for pharma industry
    The Washington Post is reporting that President-elect Donald Trump’s transition website may be hinting to drug and medical device makers that under his administration, it might be easier to get their treatments to patients. The transition site promises that as president, Trump will “reform the Food and Drug Administration to put greater focus on the need of patients for new and innovative medical products.”
     

  • Study: Childhood exposure to flu protects against future strains

    PHOENIX - Your birth year predicts -- to a certain extent - how likely you are to get seriously ill or die in an outbreak of an animal-origin influenza virus, according to a study published last week that was co-led by researchers from the University of Arizona in Tucson and the University of California, Los Angeles.

  • Allergan adds new board director
    DUBLIN — Allergan on Monday announced the addition of Adriane M. Brown to its board of directors, effective February 2017. Brown serves as president and CEO of private global invention company Intellectual Ventures.
     
    "I am pleased to join the board of Allergan as they deliver results around the world that serve their customers and patients," said Brown. "Their commitment to innovative and meaningful work with the goal of helping people live longer and healthier is commendable."
     

  • WSJ: Parts of Affordable Care Act appealing to Trump
X
This ad will auto-close in 10 seconds